Founded in 2009, Hasbiotech has considered the needs of Turkish medicine while establishing its vision and mission, and focused on innovative and pioneering therapies. We are engaged in studies on drugs used for hematologic, metabolic and chronic diseases; oncology and wound treatment in particular.
Our aim is to develop new alternatives to currently available treatment options; to investigate existing biotechnological and advanced treatment methods and bring them into use; to become a worldwide company with the steps forward; to ensure the permanence of our current and future business partnerships within the context of an environment of trust; and to be an efficient, dynamic company capable of organizing rapidly and adapting to changing conditions. Additionally, Hasbiotech has also set its target on manufacturing an original Turkish medicine starting from scratch including raw materials. Within this framework, the company is currently making efforts to establish a manufacturing site for local manufacturing of biotechnological products.
We wish to ensure our company’s sustainability with flexible and innovative business development models and innovative R&D projects.